Emergency Department, ICU and Inpatient Clinical Pathway for
Evaluation/Treatment of Children with Suspected Diabetic Ketoacidosis (DKA)
60 min
ED Triage
POC glucose, POC beta-hydroxybutyrate (BOHB)
POC glucose, POC beta-hydroxybutyrate (BOHB)
Team Assessment
- History and Physical Exam
- Assess
- MS, VS, dehydration
Risk for Cerebral Edema
- MS, VS, dehydration
- IV Access
- 2 PIV
- Initial Labs
- VBG, BMP, Mg, Phos, HgbA1C
HCG, CBC as indicated
- VBG, BMP, Mg, Phos, HgbA1C
- IV Fluids
- 20 mL/kg NS over 1 hr
- Monitor
- VS q15min, I/O hourly
- Start ED RN Care Map
- DKA Confirmed
- Glucose > 200 mg/dL and
- BOHB > 3 mmol and
- pH < 7.3 or HCO3 < 15 mmol/L
Ongoing Treatment
- Care Goals
- Frequent MS, VS, PE assessment
- Initial NS bolus over 1st hr
- Insulin to start after 1st NS bolus
- Decrease blood glucose (BG)
- 50–100 mg/dL/hr
- Adjust dextrose
- Based on hourly BG
- Adjust K+
- Based on q2hr BMP/mag/phos
- ECG for < 2.5 or K > 6
| IVF Rehydration, Electrolytes, Glucose |
|
|||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||||
| Electrolyte Abnormalities in DKA Na HCO3 is not recommended |
||||||||||||||||||||||||||||||
| Regular Insulin Infusion |
|
|||||||||||||||||||||||||||||
| Labs Monitoring |
|
|||||||||||||||||||||||||||||
| Physical Monitoring |
|
|||||||||||||||||||||||||||||
| Admission Considerations | ||||||||||||||||||||||||||||||
- Resolution of DKA
- MS, VS improved, tolerating sips
- HCO3 ≥ 15 mmol/L or < 15, BOHB < 2mmol/L
- Anion gap < 10
- Transition to Subcutaneous Insulin
- Administer first rapid-acting subcutaneous insulin dose
- Ensure Lantus dose has been given
- Allow child to start eating
- Wait 20 mins, stop insulin infusion and IVF if PO adequate
- Calculating Subcutaneous Insulin Dose
- Long-acting Total Daily Dose
- Short-acting
- Carbohydrate coverage
- Correction factor
- Ketone dose
- Diabetes Care Flow Chart
Evidence
- Diabetic Ketoacidosis in Children
- ISPAD Clinical Practice Consensus Guidelines 2022: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
